Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that affects premature
infants. Despite improvements in neonatal care and management guidelines, ROP remains …

Diabetes mellitus most commonly occurs after the neonatal period and results from complex
interactions between both environmental and incompletely penetrant genetic factors …

Neonatal diabetes mellitus (DM) is defined by the onset of persistent hyperglycemia within
the first six months of life but may present up to 12 months of life. A gene mutation affecting …

Aim To study the outcomes of very preterm infants with hyperglycaemia treated with Insulin.
Methods This is a systematic review of randomised controlled trials (RCTs) and …

Objective To explore the association between hyperglycaemia and adverse outcomes in
very preterm infants. Design Systematic review and meta-analysis. Data were pooled …

Through a meta-analysis, we aimed to investigate whether neonatal hyperglycemia was
associated with an increased risk of retinopathy of prematurity (ROP) by summarizing all …

Objective To evaluate the effects of hyperglycemia on body composition and
neurodevelopment, and how early nutrition and illness modify these relationships in infants …

To determine the association between hyperglycemia, glycated albumin (GlyA) and
retinopathy of prematurity (ROP). Prospective study of all infants under ROP screening from …

Aim The present study was designed to determine whether there was an association
between Mean Platelet Volume (MPV) in predicting poor fetal outcome, insulin resistance …

Background Most preterm infants require a continuous glucose infusion in the early
postnatal period due to the interruption of the transplacental glucose supply after birth to …